Cargando…

Nitric oxide-releasing nanoparticles improve doxorubicin anticancer activity

PURPOSE: Anticancer drug delivery systems are often limited by hurdles, such as off-target distribution, slow cellular internalization, limited lysosomal escape, and drug resistance. To overcome these limitations, we have developed a stable nitric oxide (NO)-releasing nanoparticle (polystyrene-malei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alimoradi, Houman, Greish, Khaled, Barzegar-Fallah, Anita, Alshaibani, Lama, Pittalà, Valeria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251458/ https://www.ncbi.nlm.nih.gov/pubmed/30538458 http://dx.doi.org/10.2147/IJN.S187089

Ejemplares similares

Data characterizing the biophysical and nitric oxide release properties of the tDodSNO – Styrene maleic anhydride nanoparticle SMA-tDodSNO
por: Alimoradi, Houman, et al.
Publicado: (2018)

Controlled Delivery of Nitric Oxide for Cancer Therapy
por: Alimoradi, Houman, et al.
Publicado: (2019)

Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer
por: Bahman, Fatemah, et al.
Publicado: (2021)

In Vivo Evaluation of Anti-Nociceptive Effects of Silver Nanoparticles
por: Morsi, Shereen, et al.
Publicado: (2022)

Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells
por: Pittalà, Valeria, et al.
Publicado: (2017)

Selective Targeting of Breast Cancer by Tafuramycin A Using SMA-Nanoassemblies
por: El-Deeb, Ibrahim M., et al.
Publicado: (2021)

Enzyme-responsive doxorubicin release from dendrimer nanoparticles for anticancer drug delivery
por: Lee, Sang Joon, et al.
Publicado: (2015)

Nitric oxide-releasing porous silicon nanoparticles
por: Kafshgari, Morteza Hasanzadeh, et al.
Publicado: (2014)

Comparison of Doxorubicin Anticancer Drug Loading on Different Metal Oxide Nanoparticles
por: Javed, Khalid Rashid, et al.
Publicado: (2015)

Control of systemic inflammation through early nitric oxide supplementation with nitric oxide releasing nanoparticles
por: Williams, Alexander T., et al.
Publicado: (2020)

From Far West to East: Joining the Molecular Architecture of Imidazole-like Ligands in HO-1 Complexes
por: Floresta, Giuseppe, et al.
Publicado: (2021)

The Potential Role of Sildenafil in Cancer Management through EPR Augmentation
por: Haider, Mohamed, et al.
Publicado: (2021)

The Promise of Nanotechnology in Personalized Medicine
por: Alghamdi, Maha Ali, et al.
Publicado: (2022)

Novel Structural Insight into Inhibitors of Heme Oxygenase-1 (HO-1) by New Imidazole-Based Compounds: Biochemical and In Vitro Anticancer Activity Evaluation
por: Greish, Khaled F., et al.
Publicado: (2018)

Novel Heme Oxygenase-1 (HO-1) Inducers Based on Dimethyl Fumarate Structure
por: Sorrenti, Valeria, et al.
Publicado: (2020)

Curcumin–Copper Complex Nanoparticles for the Management of Triple-Negative Breast Cancer
por: Greish, Khaled, et al.
Publicado: (2018)

Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity
por: Pieper, Sebastian, et al.
Publicado: (2019)

Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer
por: Haider, Mohamed, et al.
Publicado: (2022)

Nitric Oxide Releasing Nanoparticles for Treatment of Candida Albicans Burn Infections
por: Macherla, Chitralekha, et al.
Publicado: (2012)

Anticancer potential of nitric oxide (NO) in neuroblastoma treatment
por: Gordon, Jenna L., et al.
Publicado: (2021)

The Role of Nitric Oxide in Doxorubicin-Induced Cardiotoxicity: Experimental Study
por: Bahadır, Ayşenur, et al.
Publicado: (2014)

Heme Oxygenase Modulation Drives Ferroptosis in TNBC Cells
por: Consoli, Valeria, et al.
Publicado: (2022)

Nitric oxide-releasing poly(lactic-co-glycolic acid)-polyethylenimine nanoparticles for prolonged nitric oxide release, antibacterial efficacy, and in vivo wound healing activity
por: Nurhasni, Hasan, et al.
Publicado: (2015)

Magnetic Properties of Polyvinyl Alcohol and Doxorubicine Loaded Iron Oxide Nanoparticles for Anticancer Drug Delivery Applications
por: Nadeem, Muhammad, et al.
Publicado: (2016)

Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics
por: Mintz, Joel, et al.
Publicado: (2021)

Tobacco Xenobiotics Release Nitric Oxide
por: Lam, EWN, et al.
Publicado: (2003)

Tobacco Xenobiotics Release Nitric Oxide
por: Lam, EWN, et al.
Publicado: (2003)

Nitric oxide generating/releasing materials
por: Liang, Hongying, et al.
Publicado: (2015)

New Arylethanolimidazole Derivatives as HO-1 Inhibitors with Cytotoxicity against MCF-7 Breast Cancer Cells
por: Ciaffaglione, Valeria, et al.
Publicado: (2020)

Inducing angiogenesis with the controlled release of nitric oxide from biodegradable and biocompatible copolymeric nanoparticles
por: Yang, Chungmo, et al.
Publicado: (2018)

Nitric Oxide-Releasing Nanoparticles Are Similar to Efinaconazole in Their Capacity to Eradicate Trichophyton rubrum Biofilms
por: Costa-Orlandi, Caroline Barcelos, et al.
Publicado: (2021)

Control of Orthodontic Tooth Movement by Nitric Oxide Releasing Nanoparticles in Sprague-Dawley Rats
por: Crawford, Derrick, et al.
Publicado: (2022)

Nitric Oxide-Mediated Enhancement and Reversal of Resistance of Anticancer Therapies
por: Hays, Emily, et al.
Publicado: (2019)

Doxorubicin and Aclarubicin: Shuffling Anthracycline Glycans for Improved Anticancer Agents
por: Wander, Dennis P. A., et al.
Publicado: (2020)

Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia
por: Ciaffaglione, Valeria, et al.
Publicado: (2022)

Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles
por: Chen, Yan, et al.
Publicado: (2011)

Poly(3-Hydroxybutyrate)-Based Nanoparticles for Sorafenib and Doxorubicin Anticancer Drug Delivery
por: Babos, György, et al.
Publicado: (2020)

Progress and Promise of Nitric Oxide‐Releasing Platforms
por: Yang, Tao, et al.
Publicado: (2018)

Development of Antimicrobial Nitric Oxide-Releasing Fibers
por: Wang, Daniel C., et al.
Publicado: (2021)

Non-viral nitric oxide-based gene therapy improves perfusion and liposomal doxorubicin sonopermeation in neuroblastoma models
por: Bellary, Aditi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qkiph68679socmc4urgqfjgq1h